StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.29−0.44 (-6.54%)

Close on Nov 16, 2026Market cap $283.18MP/E –Yield –

Agenus total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Agenus's total debt was $30.07M at Jun 30, 2026. For fiscal 2025 it was $44.66M, up 34.6% from the year before. Over ten years it grew -9.0% a year on average. The highest annual figure on record is $163.02M in fiscal 2017.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$44.66M+34.6%
FY2024Dec 31, 2024$33.17M+156.9%
FY2023Dec 31, 2023$12.91M-1.9%
FY2022Dec 31, 2022$13.16M-2.9%
FY2021Dec 31, 2021$13.55M-31.3%
FY2020Dec 31, 2020$19.71M+40.5%
FY2019Dec 31, 2019$14.03M+5.0%
FY2018Dec 31, 2018$13.36M-91.8%
FY2017Dec 31, 2017$163.02M+24.7%
FY2016Dec 31, 2016$130.69M+14.2%
FY2015Dec 31, 2015$114.47M+1799.5%
FY2014Dec 31, 2014$6.03M+71.3%
FY2013Dec 31, 2013$3.52M+1624.0%
FY2012Dec 31, 2012$204.09K+3.2%
FY2011Dec 31, 2011$197.68K+35.3%
FY2010Dec 31, 2010$146.06K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$30.07M-11.2%
Q1 FY2026Mar 31, 2026$30.19M-10.1%
Q4 FY2025Dec 31, 2025$44.66M+34.6%
Q3 FY2025Sep 30, 2025$34.21M+155.3%
Q2 FY2025Jun 30, 2025$33.87M+152.3%
Q1 FY2025Mar 31, 2025$33.58M+147.3%
Q4 FY2024Dec 31, 2024$33.17M+156.9%
Q3 FY2024Sep 30, 2024$13.40M+2.2%
Q2 FY2024Jun 30, 2024$13.43M+1.0%
Q1 FY2024Mar 31, 2024$13.58M-0.5%
Q4 FY2023Dec 31, 2023$12.91M-1.9%
Q3 FY2023Sep 30, 2023$13.11M-2.6%
Q2 FY2023Jun 30, 2023$13.30M-2.9%
Q1 FY2023Mar 31, 2023$13.65M-3.8%
Q4 FY2022Dec 31, 2022$13.16M-2.9%
Q3 FY2022Sep 30, 2022$13.46M+1.0%
Q2 FY2022Jun 30, 2022$13.70M-30.8%
Q1 FY2022Mar 31, 2022$14.18M-30.4%
Q4 FY2021Dec 31, 2021$13.55M-31.3%
Q3 FY2021Sep 30, 2021$13.33M-33.4%
Q2 FY2021Jun 30, 2021$19.79M-2.8%
Q1 FY2021Mar 31, 2021$20.38M+54.0%
Q4 FY2020Dec 31, 2020$19.71M+40.5%
Q3 FY2020Sep 30, 2020$20.03M+44.6%
Q2 FY2020Jun 30, 2020$20.35M+48.7%
Q1 FY2020Mar 31, 2020$13.23M-2.1%
Q4 FY2019Dec 31, 2019$14.03M+5.0%
Q3 FY2019Sep 30, 2019$13.85M+4.9%
Q2 FY2019Jun 30, 2019$13.68M+4.8%
Q1 FY2019Mar 31, 2019$13.52M+4.7%
Q4 FY2018Dec 31, 2018$13.36M-91.8%
Q3 FY2018Sep 30, 2018$13.20M-90.8%
Q2 FY2018Jun 30, 2018$13.05M-90.6%
Q1 FY2018Mar 31, 2018$12.91M-90.4%
Q4 FY2017Dec 31, 2017$163.02M+24.7%
Q3 FY2017Sep 30, 2017$143.25M+13.3%
Q2 FY2017Jun 30, 2017$138.68M–
Q1 FY2017Mar 31, 2017$134.30M–
Q4 FY2016Dec 31, 2016$130.69M–
Q3 FY2016Sep 30, 2016$126.41M–

More Agenus figures

See a number that looks wrong?